Managing Priapism in Sickle Cell Disease: A Clinical Framework for Urologists

Priapism represents one of the more demanding urological emergencies, particularly when it arises in the context of sickle cell disease, where recurrent ischemic episodes can lead to permanent erectile tissue damage if intervention is delayed. Prolonged penile erection lasting more than four hours unrelated to sexual stimulation requires immediate assessment to distinguish ischemic (low-flow) from non-ischemic (high-flow) aetiology. In men with sickle cell disease, the overwhelming majority of episodes are ischemic, driven by venous outflow obstruction and cavernosal hypoxia.

Sickle cell disease produces its vaso-occlusive complications through polymerisation of haemoglobin S within erythrocytes, causing rigid cells that obstruct the microvasculature. The cavernosal sinusoids are particularly vulnerable because of their sluggish flow at baseline, and sickling within these spaces initiates a cycle of stasis, acidosis and further polymerisation. Endothelial dysfunction, nitric oxide depletion and dysregulated phosphodiesterase activity amplify the problem, creating a molecular environment that favours prolonged smooth muscle contraction and impaired relaxation.

In Australia, sickle cell disease is less prevalent than in parts of the Mediterranean, the Middle East or sub-Saharan Africa, yet significant patient cohorts exist in metropolitan centres with multicultural populations. Clinicians at Sydney's Royal Prince Alfred Hospital, the Royal Melbourne Hospital and the Princess Alexandra Hospital in Brisbane manage patients referred from across New South Wales, Victoria and Queensland. Aboriginal and Torres Strait Islander communities also have documented haemoglobinopathy variants that occasionally present with similar complications, making familiarity with this presentation broadly relevant.

A multidisciplinary response is essential. Urologists work alongside haematologists, emergency physicians, transfusion medicine specialists and chronic disease nurses to coordinate acute, intermediate and long-term care. Contemporary guidance published through the Taiwan Urological Association and reflected in Australian protocols emphasises that isolated surgical or medical treatment without haematological optimisation often produces inferior outcomes. Recognising this interconnected pathway underpins the framework discussed below.

Pathophysiology and Ischaemic Mechanisms

The core lesion in sickle cell-related priapism is microvascular obstruction of the cavernosal venous outflow by sickled erythrocytes, exacerbated by compromised arterial inflow and impaired smooth muscle relaxation. Histological studies of cavernosal tissue retrieved during shunt procedures demonstrate trabecular fibrosis, smooth muscle necrosis and architectural disorganisation that mirror the severity of prior ischaemic insults. These changes explain why each successive episode carries a higher risk of permanent erectile dysfunction.

Nitric oxide bioavailability falls sharply within the hypoxic cavernosal environment, removing the principal mediator of penile detumescence. Simultaneously, raised endothelin-1 and altered adenosine signalling sustain contraction. The result is a self-reinforcing cycle where hypoxia worsens sickling, which worsens hypoxia. Clinicians evaluating patients at presentation should recognise that the apparent rigidity often masks an ischaemic process that is already damaging the erectile tissue.

Diagnostic differentiation from non-ischemic priapism is critical, as treatment pathways diverge substantially. Cavernosal blood gas analysis typically reveals a pO₂ below 30 mmHg and a pH below 7.25 in ischaemic priapism, compared with arterialised values in high-flow cases. Colour Doppler ultrasound in the emergency department or radiology suite further refines the diagnosis by demonstrating markedly diminished or absent cavernosal arterial inflow.

Acute Management in the Emergency Setting

The first therapeutic objective is to restore cavernosal oxygenation and achieve detumescence. Intracavernosal aspiration using a 19-gauge butterfly needle inserted into the lateral aspect of the corpus cavernosum remains the cornerstone initial manoeuvre. Irrigation with warmed saline through a three-way tap facilitates removal of hypoxic, hypercapnic and acidic blood, and is performed in parallel with intracavernosal injection of dilute phenylephrine.

Phenylephrine, a selective alpha-1 agonist, is administered in 100–200 microgram aliquots every five minutes, up to a maximum of 1 mg, with blood pressure checks throughout. Patients should be on continuous cardiac monitoring because of the risk of hypertensive response, particularly in older men or those with cardiac comorbidities. This approach achieves detumescence in the majority of presentations when delivered within the first six to twelve hours, underscoring the importance of early presentation and rapid triage.

Australian emergency departments in major tertiary centres have adopted standardised priapism protocols that parallel those used for testicular torsion, ensuring that time-critical interventions are not delayed by junior staff unfamiliarity. Where initial aspiration and pharmacological injection fail, the urologist on call proceeds to surgical shunt creation without further delay, because cavernosal pressures above 60 mmHg sustained beyond twelve hours reliably produce irreversible tissue damage.

Haematological Interventions and Transfusion

Concurrent haematological management targets the underlying sickle cell crisis. Hydration with isotonic fluids, analgesia titrated to patient-reported pain, supplemental oxygen and warmth form the basic supportive package. Simple top-up transfusion may be sufficient when haemoglobin levels have fallen, but exchange transfusion is preferred for severe episodes because it rapidly reduces the proportion of haemoglobin S without producing hyperviscosity.

In Australia, exchange transfusion is coordinated through hospital blood banks working to Australian and New Zealand Society of Blood Transfusion standards, with the Australian Red Cross Lifeblood supplying phenotype-matched components. Close liaison between the treating urologist and a haematologist with sickle cell expertise ensures that transfusion thresholds, target haemoglobin S percentages and anticoagulation considerations are addressed comprehensively.

Recurrent stuttering priapism episodes often precede a major ischaemic event and warrant a proactive transfusion plan rather than reactive management after each presentation. Some Australian centres have adopted chronic transfusion programs similar to those used for stroke prevention in paediatric sickle cell disease, with the dual aim of reducing haematological crises and the priapism episodes that frequently accompany them.

Prevention and Long-Term Medical Strategies

Preventing recurrent priapism requires a sustained outpatient strategy. Hydroxyurea, the foundational disease-modifying agent in sickle cell disease, increases foetal haemoglobin production and reduces haemoglobin S polymerisation, with observational evidence suggesting a meaningful reduction in priapism frequency. Australian prescribers follow haematology-led protocols with regular monitoring of blood counts and renal function.

Adjunctive oral agents include pseudoephedrine and etilefrine, alpha-adrenergic agonists that counter nocturnal smooth muscle contraction. PDE5 inhibitors such as tadalafil and sildenafil occupy a counterintuitive but evidence-supported role; chronic low-dose administration appears to normalise the altered NO-cGMP axis within cavernosal tissue and reduce stuttering episodes. Patients should be counselled that the goal is prevention rather than acute treatment, distinguishing this from on-demand erectile dysfunction prescribing.

Patient-led self-management is equally important. Education delivered through specialist nurses at clinics in Sydney, Melbourne and Perth teaches men to recognise early warning signs, to use at-home pseudoephedrine as directed, and to seek emergency care without delay when an episode exceeds two hours. Written action plans adapted to local emergency department locations improve time-to-presentation, which remains the single most important determinant of functional outcome.

Surgical Options for Refractory Cases

When aspiration, intracavernosal injection and conservative measures fail to resolve the acute episode, shunt surgery becomes necessary. Distal shunts, including the Winter and Ebbehoj techniques and the more contemporary T-shunt with or without tunnelling, create a communication between the corpus cavernosum and the corpus spongiosum. These procedures are preferred as first-line surgical options because of their relative simplicity and acceptable complication profiles.

Proximal shunts such as the Quackels and Grayhack procedures carry greater risk of urethral injury and subsequent cavernositis but remain options when distal shunts are unsuccessful. The choice of technique depends on the duration of the episode, surgeon experience and intraoperative findings. Early consultation with a urologist experienced in andrological surgery, often available at quaternary centres including those affiliated with the author guidelines framework for andrology practice, improves outcomes.

For men who progress to refractory erectile dysfunction despite timely intervention, penile prosthesis implantation offers reliable restoration of sexual function. Implantation is best deferred until the acute inflammatory phase has passed and the patient has completed rehabilitation, usually several months after the last episode. Australian data, discussed in work that complements emerging biomarker research such as emerging prostate cancer diagnostics, underscore the value of individualised prosthetic counselling that accounts for patient priorities, anatomy and prior surgical history.

Long-Term Outcomes and Quality of Life

The long-term prognosis for erectile function depends heavily on the duration and frequency of prior ischaemic episodes. Episodes resolved within twelve hours carry favourable outcomes, while those persisting beyond twenty-four hours frequently result in permanent erectile dysfunction despite technically successful shunt surgery. Honest preoperative counselling about these probabilities allows patients to plan psychologically and to engage with rehabilitation services.

Psychosocial support is integral to recovery. Recurrent priapism, particularly in adolescents and young adults, carries an emotional burden that affects identity, relationships and treatment adherence. Australian sickle cell advocacy groups and clinical psychologists embedded within haemoglobinopathy clinics provide crucial continuity of care, particularly during the transition from paediatric to adult services that often coincides with peak priapism incidence.

Surveillance should include periodic penile Doppler studies, structured erectile function assessment using validated instruments and ongoing haematology review. Coordinated care pathways that document each acute presentation, every transfusion episode and all surgical interventions create a longitudinal record that informs future management. For urologists interested in contributing to the evidence base, parallels exist with ongoing research into other urological complications; curious readers can explore adjacent work via the casino cold wallet connect reference for broader context on interdisciplinary clinical frameworks.

Comprehensive management of priapism in sickle cell disease patients demands integration of acute urological intervention, haematological optimisation, preventive pharmacology and long-term psychosocial support. Australian clinicians working in major metropolitan centres are well placed to deliver this multidisciplinary care, drawing on established transfusion services, andrological surgery expertise and patient advocacy networks. Submit your case series or review to Urological Science and contribute to the growing body of evidence that guides this challenging clinical territory.